The prevalence, disease burden and prognosis of COPD in patients with cardiovascular diseases - PRECEDE

Exclusion Criteria

• 1.Significant diseases or conditions, which, in the opinion of the investigator, may put the subject at risk because of participation in the study or may influence either the results of the study or the subject’s ability to participate in the study.
• 2.Women who are pregnant or lactating or are planning to become pregnant, or women of childbearing potential who are not using an acceptable method of contraception.
• 3.Subjects who are not able to provide written informed consent.
• 4.Treatment with investigational study drug or device in another clinical study within the last 30 days or five half lives prior to baseline visit , whichever is longer.